| 1 |
35345577 | Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan. | 2022 |
6 |
| 2 |
33955183 | The angiotensin II type 1 receptor blocker valsartan in the battle against COVID-19. | 2021 Sep |
3 |
| 3 |
32087363 | Systematic characterization of AT1 receptor antagonists with label-free dynamic mass redistribution assays. | 2020 Mar - Apr |
1 |
| 4 |
33203141 | The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19. | 2020 Nov 15 |
1 |
| 5 |
30998981 | Downregulation of AT2R decreases the responsiveness of BKCa channels to angiotensin II in patients with hypertension. | 2019 Jun |
1 |
| 6 |
31307032 | Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR. | 2019 |
1 |
| 7 |
31803758 | Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts. | 2019 |
1 |
| 8 |
29500454 | The effects of angiotensin receptor neprilysin inhibition by sacubitril/valsartan on adipose tissue transcriptome and protein expression in obese hypertensive patients. | 2018 Mar 2 |
1 |
| 9 |
30212210 | Trans and Cis Conformations of the Antihypertensive Drug Valsartan Respectively Lock the Inactive and Active-like States of Angiotensin II Type 1 Receptor: A Molecular Dynamics Study. | 2018 Oct 22 |
1 |
| 10 |
27542885 | Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension. | 2017 Feb |
2 |
| 11 |
28178430 | Nitric oxide synthesis-promoting effects of valsartan in human umbilical vein endothelial cells via the Akt/adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway. | 2017 May 20 |
2 |
| 12 |
28338173 | Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells. | 2017 Mar |
8 |
| 13 |
26931777 | Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects. | 2016 Nov |
1 |
| 14 |
27719743 | Effect of food on the oral bioavailability of the angiotensin receptor - neprilysin inhibitor sacubitril/valsartan (LCZ696) in healthy subjects
. | 2016 Dec |
1 |
| 15 |
28164602 | Effects of Angiotensin Inhibitor Valsartan on the Expression of the Angiotensin II 1 Receptor, Matrix Metalloproteinases -2 and -9 in Human Bladder Cancer Cell Lines. | 2016 Aug 1 |
4 |
| 16 |
25591555 | Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension. | 2015 Jan 20 |
2 |
| 17 |
26223916 | Regulatory effects of AT₁R-TRAF6-MAPKs signaling on proliferation of intermittent hypoxia-induced human umbilical vein endothelial cells. | 2015 Aug |
1 |
| 18 |
24372930 | Temporal association as a prerequisite factor of valsartan-induced lithium toxicity. | 2014 Sep |
1 |
| 19 |
24844704 | Valsartan reverses depressive/anxiety-like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice. | 2014 Sep |
1 |
| 20 |
25109475 | Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions. | 2014 Oct |
1 |
| 21 |
25346502 | Valsartan blocked alcohol-induced, Toll-like receptor 2 signaling-mediated inflammation in human vascular endothelial cells. | 2014 Oct |
1 |
| 22 |
25762441 | Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway. | 2014 |
1 |
| 23 |
22803969 | Thermal behavior and phase identification of Valsartan by standard and temperature-modulated differential scanning calorimetry. | 2013 Oct |
2 |
| 24 |
23426512 | [Angiotensin II activates large-conductance Ca(2+)-activated potassium channels in human mesenteric artery smooth muscle cells]. | 2013 Feb 25 |
1 |
| 25 |
23553863 | The effects of long-term valsartan treatment on skeletal muscle fatty acid handling in humans with impaired glucose metabolism. | 2013 May |
2 |
| 26 |
24070321 | Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker? | 2013 Nov |
1 |
| 27 |
24219285 | Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts. | 2013 Dec |
1 |
| 28 |
22045314 | Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes. | 2012 Feb 1 |
2 |
| 29 |
22768174 | Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial. | 2012 |
1 |
| 30 |
22884153 | Different effects of telmisartan and valsartan on human aortic vascular smooth muscle cell proliferation. | 2012 Jun |
1 |
| 31 |
23038657 | Characterization of new organic nitrate hybrid drugs covalently bound to valsartan and cilostazol. | 2012 |
1 |
| 32 |
21315062 | Interactions of the AT1 antagonist valsartan with dipalmitoyl-phosphatidylcholine bilayers. | 2011 Jun |
2 |
| 33 |
20399995 | Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers. | 2010 Mar |
1 |
| 34 |
20432929 | [The effect of angiotensin II on phosphoinositide-3 kinase/Akt cascade in cultured fibroblasts derived from patients with hypertrophic scars]. | 2010 Jan |
1 |
| 35 |
20463030 | Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. | 2010 Jul 16 |
1 |
| 36 |
19256500 | Antihypertensive drug valsartan in solution and at the AT1 receptor: conformational analysis, dynamic NMR spectroscopy, in silico docking, and molecular dynamics simulations. | 2009 Mar |
3 |
| 37 |
19307231 | Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. | 2009 Jun 1 |
7 |
| 38 |
19687742 | Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation. | 2009 Nov |
1 |
| 39 |
19843489 | Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. | 2009 Sep |
1 |
| 40 |
19911855 | Valsartan: more than a decade of experience. | 2009 |
1 |
| 41 |
17878892 | Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. | 2008 Feb |
1 |
| 42 |
17322151 | Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients. | 2007 Mar |
1 |
| 43 |
17393691 | [Role of angiotensin II receptors in proliferation of fibroblast derived from human hypertrophic scars]. | 2007 Jan |
1 |
| 44 |
17875818 | Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. | 2007 Nov |
1 |
| 45 |
17964282 | Oxidation of Prx2 and phosphorylation of GRP58 by angiotensin II in human coronary smooth muscle cells identified by 2D-DIGE analysis. | 2007 Dec 28 |
2 |
| 46 |
16713009 | The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension. | 2006 Dec |
1 |
| 47 |
17086018 | Angiotensin receptor blockade improves vascular compliance in healthy normotensive elderly individuals: results from a randomized double-blind placebo-controlled trial. | 2006 Nov |
1 |
| 48 |
15677497 | Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress. | 2005 Feb |
1 |
| 49 |
15907144 | Angiotensin antagonism in coronary artery disease: results after coronary revascularisation. | 2005 |
1 |
| 50 |
16097371 | Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells. | 2005 Mar |
1 |